About Kenneth Slavik
Dr. Slavik is the Chief Science Officer for the Philadelphia College of Osteopathic Medicine, responsible for overseeing the institution's research process and operations, and expanding the research contributions of PCOM scientists.
|2016||Chief Science Officer, Division of Research, Philadelphia College of Osteopathic Medicine ‐ Research Division|
Research Planning and Cardiovascular Signaling
p: 215 871-6654
Scholarly Articles (8)
Loss of adenosine-induced negative inotropic effect in hyperexcited rabbit hearts ...
American Journal of Physiology - Heart and Circulatory Physiology (1995)
Adenosine produced a negative inotropic effect in hearts isolated from calm rabbits but not from those exhibiting alarm behavior during ...
Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia
Journal of Pharmacology and Experimental Therapeutics (1993)
The objective of this investigation was to test the hypothesis that naloxone directly activates alpha-2 adrenoceptors to cause depression of ...